TP53 and breast carcinoma: We propose that efficacy of breast cancer treatment and reduction of recurrence post therapy where p14ARF-p53 is activated (such as radiation and chemotherapy) can be improved by the use of combination therapies with anti-estrogens in hormone-dependent breast cancer.